Balancing Anticoagulation Decisions in Patients on Dialysis with Atrial Fibrillation

[摘要] For over 20% of 678,000 patients with ESRD in the United States, the diagnosis of atrial fibrillation (AF) presents a clinical conundrum.[1][1] Patients receiving hemodialysis (HD) not only have a higher prevalence of AF, but also are at greater risk of heart failure, hypertension, and diabetes[2][2.

[学科分类] 泌尿医学